A novel approach for discovering human behavior patterns using unsupervised methods

Wang, Ju; Bauer, Jürgen; Becker, Marcus; Bente, Petra; Dasenbrock, Lena; Elbers, Katharina; Hein, Andreas; Kohlmann, Martin; Kolb, Gerald; Lammel-Polchau, Christopher; Marschollek, Michael; Meis, Markus; Remmers, Hartmut; Schwabedissen, H. Meyer zu; Schulze, Mareike; Steen, Enno-Edzard; Haux, Reinhold; Wolf, Klaus-Hendrik

doi:10.1007/s00391-014-0806-7

Cited by 9 publications

(5 citation statements)

References 17 publications

(16 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Technology-based objective measures (TOMs) offer an alternative to questionnaires [ 29 ]. Options range from motion sensors to smart home technology, which consists of a combination of sensors and connected devices that monitor (and control if needed) the use of appliances at home [ 30 ]. These systems can monitor several iADLs at home, such as the ability to perform online banking or the time spent watching television or sleeping [ 31 ].…”

Section: Methodsmentioning

confidence: 99%

Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

Rodríguez‐Porcel

Wyman‐Chick

Ruiz

et al. 2022

Transl Neurodegener

View full text Add to dashboard Cite

The selection of appropriate outcome measures is fundamental to the design of any successful clinical trial. Although dementia with Lewy bodies (DLB) is one of the most common neurodegenerative conditions, assessment of therapeutic benefit in clinical trials often relies on tools developed for other conditions, such as Alzheimer’s or Parkinson’s disease. These may not be sufficiently valid or sensitive to treatment changes in DLB, decreasing their utility. In this review, we discuss the limitations and strengths of selected available tools used to measure DLB-associated outcomes in clinical trials and highlight the potential roles for more specific objective measures. We emphasize that the existing outcome measures require validation in the DLB population and that DLB-specific outcomes need to be developed. Finally, we highlight how the selection of outcome measures may vary between symptomatic and disease-modifying therapy trials.

show abstract

Section: Methodsmentioning

confidence: 99%

Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

Rodríguez‐Porcel

Wyman‐Chick

Ruiz

et al. 2022

Transl Neurodegener

View full text Add to dashboard Cite

show abstract

“…Of particular importance were trans-institutional information system architectures and infrastructures, which can also use newly-available sensor technologies for tasks of prevention and diagnostics, while taking into account data protection and informational self-determination [23,24]. This research should have contributed to a better understanding of how trans-institutional care processes should look like and how assistive technologies can be used and contribute to the quality of life and adequate care of senior citizens.…”

Section: • the Research Network 'Design Ofmentioning

confidence: 99%

Reflections Towards the Future of Medical Informatics

Haux¹

2023

Yearb Med Inform

Self Cite

View full text Add to dashboard Cite

Objective: To provide guidance on the future development and role of medical informatics, or biomedical and health informatics, in form of reflections. Method: To report on the author’s previous activities as a medical informatician, which spans almost half a century. It began in 1973 when he started to study medical informatics. In 1978, more than four decades ago, his professional work started. He retired at the end of summer semester 2021. This was the occasion to prepare this farewell lecture. Results: In twenty reflections, thoughts are presented on professional careers (R1 – ‘places’), on medical informatics as discipline (R2 – ‘interdisciplinarity’, R3 – ‘focuses’, R4 – ‘affiliations’), on research (R5 – ‘duality’, R6 – ‘confluences’, R7 – ‘correlations’, R8 – ‘collaboration’), on education (R9 – ‘community’, R10 – ‘competencies’, R11 – ‘approaches’), on academic self-governance (R12 – ‘autonomy’), on engagement (R13 – ‘Sisyphos’, R14 – ‘professional societies’, R15 – ‘respect’, R16 – ‘tightrope walk’), and on good scientific practice (R17 – ‘time invariants’, R18 – ‘Zeitgeist’, R19 – ‘knowledge gain’, R20 – ‘exercising’). Conclusions: It has been a pleasure for me to participate in medical informatics activities for almost fifty years. During that time, there have been significant advances, including in medicine and in informatics, and also in medical informatics itself. And now it is the turn of others. While keeping in mind that tradition is not preserving the ashes, but passing on the fire, this report with its reflections may be of some help.

show abstract

“…Die Studie belegte klar die technische Machbarkeit unter Praxisbedingungen (unseres Wissens zum ersten Mal). Zudem konnte (unseres Wissens ebenfalls zum ersten Mal) gezeigt werden, dass in Wohnungen über technische Assistenzsysteme Aktivitätsmuster gemessen werden können, die neue wichtige Informationen für eine verbesserte ärztliche und pflegerische Versorgung enthielten (Wang et al 2014). ◄…”

Section: Beispiel 2: Gal-natars-studieunclassified

Methodisch-technische Aspekte der Evaluation erweiterten Zusammenwirkens

Haux

Karafyllis

2021

Zusammenwirken Von Natürlicher Und Künstlicher Intelligenz

Self Cite

View full text Add to dashboard Cite

ZusammenfassungIm Querschnittsfeld Technik und Medizin wird aus Informatik und Philosophie die Frage bearbeitet, welche Werte und Evaluationskriterien beim erweiterten Zusammenwirken von Menschen und Maschinen zu berücksichtigen sind. Das in der VDI-Richtlinie 3780 zur Technikbewertung enthaltene Werteoktogon, das acht grundlegende Werte technischen Handelns zueinander in Beziehung setzt und das Abwägungsentscheidungen für Politik und Gesellschaft ermöglichen soll, wird besprochen. Nach Einführung der aktuell verwendeten Evaluationsmethodik in der klinischen Medizin, dort insbesondere in der Therapieforschung, wird diskutiert, inwieweit diese Evaluationsansätze sich auch auf Fragen bestmöglicher Diagnostik und Therapie, Prävention und Nachsorge im erweiterten Zusammenwirken von Menschen und Maschinen angewandt werden können. Es wird ausgeführt, dass zu der Evaluation dieses Zusammenwirkens ein hoher interdisziplinärer Forschungsbedarf besteht und dass adäquate Ausbildungsangebote vorhanden sein sollten.

show abstract

A novel approach for discovering human behavior patterns using unsupervised methods

Abstract: Merely environmental data were used and no wearable sensor for activity detection or vital parameter measurement is taken into account. Therefore, this cannot comprehensively reflect reality.

Cited by 9 publications

References 17 publications

Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

Reflections Towards the Future of Medical Informatics

Methodisch-technische Aspekte der Evaluation erweiterten Zusammenwirkens

Contact Info

Product

Resources

About